• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前红细胞分布宽度变化对食管鳞癌患者临床及预后的意义。

Clinical and prognostic significance of perioperative change in red cell distribution width in patients with esophageal squamous cell carcinoma.

机构信息

Department of Radiology Physics, Key Laboratory of Radiation Oncology of Zhejiang Province, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

Department of Clinical Laboratory, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

出版信息

BMC Cancer. 2023 Apr 6;23(1):319. doi: 10.1186/s12885-023-10804-7.

DOI:10.1186/s12885-023-10804-7
PMID:37024853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10080779/
Abstract

BACKGROUND

Numerous studies have reported the prognostic significance of the red cell distribution width (RDW) in patients with esophageal squamous cell carcinoma (ESCC), but the relationship between the perioperative change in RDW (delta RDW) and survival in patients with ESCC after surgery has not been evaluated.

METHODS

A total of 594 patients with newly diagnosed ESCC after surgery were enrolled in the study. Delta RDW (delta RDW = Postoperative RDW-Preoperative RDW) was counted based on data within one week before surgery and two weeks after surgery. To investigate the relationship between delta RDW and overall survival (OS), the median delta RDW was chosen as the cut-off value.

RESULTS

99 (16.7%) patients had pathological stage 1a-1b, 202 (34.0%) patients had pathological stage 2a-2b, and 293 (49.3%) patients had pathological stage 3a-3c.There were 179 (30.1%) patients who had vessel invasive, and 415 (69.9%) patients without vessel invasive. There were 216 (36.4%) patients with nerve infiltration, and 378 (63.6%) without nerve infiltration. In univariate analysis, five parameters including delta RDW(≥ 0.44 vs.<0.44) (P = 0.039, HR = 1.337, 95% CI = 1.014-1.762) significantly correlated with worse OS. Multivariate analysis revealed that delta RDW(≥ 0.44 vs.<0.44) was an independent prognostic marker for OS (P = 0.033, HR = 1.356, 95% CI = 1.025-1.793). Kaplan-Meier curves showed that delta RDW ≥ 0.44 was significantly associated with worse OS (P = 0.039). Subgroup analysis suggested that delta RDW ≥ 0.44 indicated worse survival in patients with ESCC exclusively in these subtypes such as female patients, age > 60 patients, patients with lymph node metastasis, and patients with vessel invasive.

CONCLUSIONS

Perioperative change in red cell distribution width predicts worse survival in patients with ESCC after surgery.

摘要

背景

许多研究报告了红细胞分布宽度(RDW)在食管鳞状细胞癌(ESCC)患者中的预后意义,但尚未评估手术后 ESCC 患者的 RDW 变化(delta RDW)与生存之间的关系。

方法

本研究共纳入 594 例手术后新诊断为 ESCC 的患者。根据手术前一周和手术后两周内的数据计算 delta RDW(delta RDW=术后 RDW-术前 RDW)。为了研究 delta RDW 与总生存期(OS)之间的关系,选择中位数 delta RDW 作为截断值。

结果

99 例(16.7%)患者病理分期为 1a-1b,202 例(34.0%)患者病理分期为 2a-2b,293 例(49.3%)患者病理分期为 3a-3c。179 例(30.1%)患者有血管侵犯,415 例(69.9%)患者无血管侵犯。216 例(36.4%)患者有神经浸润,378 例(63.6%)患者无神经浸润。在单因素分析中,delta RDW(≥0.44 与<0.44)(P=0.039,HR=1.337,95%CI=1.014-1.762)等 5 个参数与较差的 OS 显著相关。多因素分析显示,delta RDW(≥0.44 与<0.44)是 OS 的独立预后标志物(P=0.033,HR=1.356,95%CI=1.025-1.793)。Kaplan-Meier 曲线显示,delta RDW≥0.44 与较差的 OS 显著相关(P=0.039)。亚组分析表明,delta RDW≥0.44 仅在女性患者、年龄>60 岁患者、有淋巴结转移患者和有血管侵犯患者等 ESCC 亚组中预示着较差的生存。

结论

术后红细胞分布宽度的变化预测 ESCC 患者的生存较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/e5ca14443799/12885_2023_10804_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/dddef1a07cec/12885_2023_10804_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/ec132509950b/12885_2023_10804_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/31dfb03a98d4/12885_2023_10804_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/271d05dc75d0/12885_2023_10804_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/e5ca14443799/12885_2023_10804_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/dddef1a07cec/12885_2023_10804_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/ec132509950b/12885_2023_10804_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/31dfb03a98d4/12885_2023_10804_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/271d05dc75d0/12885_2023_10804_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/10080779/e5ca14443799/12885_2023_10804_Fig5_HTML.jpg

相似文献

1
Clinical and prognostic significance of perioperative change in red cell distribution width in patients with esophageal squamous cell carcinoma.术前红细胞分布宽度变化对食管鳞癌患者临床及预后的意义。
BMC Cancer. 2023 Apr 6;23(1):319. doi: 10.1186/s12885-023-10804-7.
2
Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355).一线化疗免疫治疗联合或不联合放疗对局部晚期或转移性食管鳞状细胞癌患者预后的影响:一项来自中国的多中心、真实世界、回顾性队列研究(NCT06478355)
Front Immunol. 2025 Jul 28;16:1633930. doi: 10.3389/fimmu.2025.1633930. eCollection 2025.
3
Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis.红细胞分布宽度对食管癌患者预后的影响:系统评价和荟萃分析。
World J Gastroenterol. 2018 May 21;24(19):2120-2129. doi: 10.3748/wjg.v24.i19.2120.
4
Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.在食管鳞状细胞癌中,纤维蛋白原通过p-AKT/p-mTOR途径促进涉及上皮-间质转化的恶性肿瘤生物学行为。
J Cancer Res Clin Oncol. 2017 Dec;143(12):2413-2424. doi: 10.1007/s00432-017-2493-4. Epub 2017 Aug 11.
5
Assessing the Predictive Power of the Hemoglobin/Red Cell Distribution Width Ratio in Cancer: A Systematic Review and Future Directions.评估血红蛋白/红细胞分布宽度比值在癌症预测中的作用:系统评价及未来方向。
Medicina (Kaunas). 2023 Dec 5;59(12):2124. doi: 10.3390/medicina59122124.
6
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.新辅助放化疗与新辅助化疗治疗食管鳞状细胞癌的比较:来自中国国家癌症中心的一项倾向评分匹配研究
J Cancer Res Clin Oncol. 2022 Apr;148(4):943-954. doi: 10.1007/s00432-021-03659-7. Epub 2021 May 19.
7
The prognostic significance of desmoplastic reaction, tumor budding and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomas.促纤维增生性反应、肿瘤芽生及肿瘤浸润淋巴细胞在食管鳞状细胞癌中的预后意义
BMC Gastroenterol. 2025 Jul 1;25(1):476. doi: 10.1186/s12876-025-03984-y.
8
Prognostic and clinical significance of tumor-associated macrophages in esophageal squamous cell carcinoma after surgery: do biomarkers and distributions matter?术后食管鳞癌中肿瘤相关巨噬细胞的预后和临床意义:生物标志物和分布重要吗?
Biosci Rep. 2024 Apr 24;44(4). doi: 10.1042/BSR20231194.
9
Clinical relevance of the red blood cell distribution width measured preoperatively as a prognostic marker in patients with distal cholangiocarcinoma undergoing pancreaticoduodenectomy.术前测量的红细胞分布宽度作为接受胰十二指肠切除术的远端胆管癌患者预后标志物的临床相关性。
Surg Today. 2025 Mar 29. doi: 10.1007/s00595-025-03005-1.
10
A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma.一种新型全身免疫炎症指数可预测食管鳞状细胞癌根治性切除术后患者的生存率和生活质量。
J Cancer Res Clin Oncol. 2017 Oct;143(10):2077-2086. doi: 10.1007/s00432-017-2451-1. Epub 2017 Jun 10.

引用本文的文献

1
Development and validation of a postoperative risk model for esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.新辅助免疫化疗后食管鳞状细胞癌术后风险模型的建立与验证
Front Med (Lausanne). 2025 Aug 4;12:1608313. doi: 10.3389/fmed.2025.1608313. eCollection 2025.
2
Higher red cell distribution width (RDW) is associated with increased all-cause and cardiovascular mortality in patients with breast cancer: A retrospective analysis of NHANES data (1999-2018).较高的红细胞分布宽度(RDW)与乳腺癌患者全因死亡率和心血管死亡率升高相关:对美国国家健康与营养检查调查(NHANES)数据(1999 - 2018年)的回顾性分析
PLoS One. 2025 Jul 28;20(7):e0328680. doi: 10.1371/journal.pone.0328680. eCollection 2025.
3

本文引用的文献

1
Inflammation: the incubator of the tumor microenvironment.炎症:肿瘤微环境的温床。
Trends Cancer. 2022 Nov;8(11):901-914. doi: 10.1016/j.trecan.2022.07.002. Epub 2022 Jul 28.
2
Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development.活性氧在慢性炎症与肿瘤发展之间架起桥梁。
Oxid Med Cell Longev. 2022 Jun 28;2022:2606928. doi: 10.1155/2022/2606928. eCollection 2022.
3
Immunotherapy for Squamous Esophageal Cancer: A Review.食管鳞癌的免疫治疗:综述
Unveiling the Prognostic Power of HRR in ICU-Admitted COPD Patients: A MIMIC-IV Database Study.
揭示HRR对入住ICU的慢性阻塞性肺疾病患者的预后预测能力:一项基于MIMIC-IV数据库的研究
Int J Chron Obstruct Pulmon Dis. 2025 Jan 6;20:11-21. doi: 10.2147/COPD.S482344. eCollection 2025.
4
The First Comprehensive Evaluation of Immuno-Inflammatory Markers for Prognosis in Esophageal Cancer Patients: A South Asian Perspective.食管癌患者预后免疫炎症标志物的首次综合评估:南亚视角
Clin Pract. 2024 Oct 6;14(5):2071-2079. doi: 10.3390/clinpract14050163.
5
Association between tumor necrosis factor receptor 2 and progression and poor prognosis of tumor stage 2‑3 esophageal squamous cell carcinoma and stratified analysis.肿瘤坏死因子受体2与2-3期食管鳞状细胞癌进展及预后不良的相关性及分层分析
Oncol Lett. 2024 Aug 21;28(5):505. doi: 10.3892/ol.2024.14638. eCollection 2024 Nov.
6
Red Cell Distribution Width as a Predictor of Survival in Patients with Hepatocellular Carcinoma.红细胞分布宽度作为肝细胞癌患者生存的预测指标。
Medicina (Kaunas). 2024 Feb 25;60(3):391. doi: 10.3390/medicina60030391.
J Pers Med. 2022 May 25;12(6):862. doi: 10.3390/jpm12060862.
4
Association of red blood cell distribution width, systemic-immune-inflammation index and poor cardiovascular outcomes in patients with newly diagnosed hypertension.红细胞分布宽度、全身免疫炎症指数与新发高血压患者心血管不良结局的相关性。
Clin Exp Hypertens. 2022 Aug 18;44(6):530-538. doi: 10.1080/10641963.2022.2079668. Epub 2022 Jun 1.
5
Survival rates and safety associated with chemoradiotherapy followed by surgery and chemoradiotherapy alone for patients with T4 esophageal cancer: a systematic review and meta-analysis.手术联合放化疗与单纯放化疗治疗 T4 期食管癌患者的生存率和安全性的系统评价和荟萃分析。
Acta Oncol. 2022 Jun;61(6):738-748. doi: 10.1080/0284186X.2022.2062680. Epub 2022 Apr 21.
6
Evaluation of diagnostic accuracy of inflammation markers [Neutrophil-Lymphocyte Ratio (NLR), Red cell Distribution Width (RDW), Prognostic Nutritional Index (PNI) and Lymphocyte Monocyte Ratio (LMR)] for outcomes in patients with acute pancreatitis.炎症标志物(中性粒细胞-淋巴细胞比值(NLR)、红细胞分布宽度(RDW)、预后营养指数(PNI)和淋巴细胞-单核细胞比值(LMR))评估急性胰腺炎患者结局的诊断准确性。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
7
Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy.微创 Ivor Lewis 食管切除术治疗食管癌的长期生存结果。
World J Surg Oncol. 2022 Feb 25;20(1):50. doi: 10.1186/s12957-022-02518-0.
8
Tumor-Infiltrating Lymphocytes as Biomarkers of Treatment Response and Long-Term Survival in Patients with Rectal Cancer: A Systematic Review and Meta-Analysis.肿瘤浸润淋巴细胞作为直肠癌患者治疗反应和长期生存的生物标志物:一项系统评价和荟萃分析
Cancers (Basel). 2022 Jan 27;14(3):636. doi: 10.3390/cancers14030636.
9
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.中国和美国 2022 年癌症统计数据:概况、趋势和决定因素。
Chin Med J (Engl). 2022 Feb 9;135(5):584-590. doi: 10.1097/CM9.0000000000002108.
10
A Different Facet of p53 Function: Regulation of Immunity and Inflammation During Tumor Development.p53功能的一个不同方面:肿瘤发生过程中免疫与炎症的调节
Front Cell Dev Biol. 2021 Oct 18;9:762651. doi: 10.3389/fcell.2021.762651. eCollection 2021.